Findings: Rodent studies showed enhanced tissue repair and improved recovery of damaged muscle and connective tissues
Tirzepatide Next-generation dual-receptor therapy Activates both GLP-1 and GIP receptors delivering superior appetite control and stronger metabolic outcomes than single-pathway medications
This selectivity has been characterized in vitro
Hypoglycemia can present with dizziness, lightheadedness, shakiness, and confusion
Zoe Quandt Our findings build on prior reports of lower cancer rates in patients on GLP-1s, showing that patients that are prescribed GLP-1s have better survival than those without these agents, particularly in comparison to the addition of insulin, Zoe Quandt, MD, MS, assistant professor in the division of diabetes, endocrinology and metabolism at the Diabetes Center at University of California, San Francisco, told Healio